Pharmacokinetic Modeling of Paracetamol Uptake and Clearance in Zebrafish Larvae: Expanding the Allometric Scale in Vertebrates with Five Orders of Magnitude

Abstract

Zebrafish larvae (Danio rerio) are increasingly used to translate findings regarding drug efficacy and safety from in vitro-based assays to vertebrate species, including humans. However, the limited understanding of drug exposure in this species hampers its implementation in translational research. Using paracetamol as a paradigm compound, we present a novel method to characterize pharmacokinetic processes in zebrafish larvae, by combining sensitive bioanalytical methods and nonlinear mixed effects modeling. The developed method allowed quantification of paracetamol and its two major metabolites, paracetamol-sulfate and paracetamol-glucuronide in pooled samples of five lysed zebrafish larvae of 3 days post-fertilization. Paracetamol drug uptake was quantified to be 0.289 pmole/min and paracetamol clearance was quantified to be 1.7% of the total value of the larvae. With an average volume determined to be 0.290 μL, this yields an absolute clearance of 2.96 × 107 L/h, which scales reasonably well with clearance rates in higher vertebrates. The developed methodology will improve the success rate of drug screens in zebrafish larvae and the translation potential of findings, by allowing the establishment of accurate exposure profiles and thereby also the establishment of concentration–effect relationships.

NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet Syndrome

“…We were interested in concentrations of drugs and solvents [30] that do not cause toxicity regardless of the exposure time and therefore chose relatively low concentrations. Regarding drug exposure time, we propose that drug should be incubated at least 90 minutes to reach a peak metabolism as shown previously [31]. Interestingly, our results mimic the results of studies that use high drug and solvent concentrations, with the only exception being Clemizole.…”

Assaying uptake of endocrine disruptor compounds in zebrafish embryos and larvae

“…In one study using high-performance liquid chromatography coupled to mass spectrometry (HPLC-MS) to measure BPA uptake into zebrafish embryos, there was a 0.02 μg/kg uptake observed following 1 nM exposure from 8-58 hpf (Saili et al, 2012). Assuming a mass of 0.291 mg per embryo (Kantae et al, 2016), this corresponds to approximately 0.025 fmol BPA per embryo. The most relevant comparison to the Saili exposure conditions that we tested is a 10 nM exposure from 24-48 hpf.…”

Tools for studying the metabolism of new psychoactive substances for toxicological screening purposes – A comparative study using pooled human liver S9, HepaRG cells, and zebrafish larvae

“…xenobiotics such as cytochrome P450 (CYP) oxygenases are identical (van Wijk et al, 2016) and zebrafish were already successfully used for metabolism studies of approved drugs (Kantae et al, 2016;Saad et al, 2017). So far, only one study has been published using zebrafish larvae in the NPS context; it was focused on distribution and toxicity studies of meta-chlorophenylpiperazine (mCPP) (Kirla et al, 2018).…”